Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference49 articles.
1. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001
2. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2008
3. Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes;Stone;Int J Radiat Oncol Biol Phys,2007
4. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007
5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up;Brachytherapy;2024-05
2. Prostate-Specific Antigen Bounce after 125I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer;Cancers;2022-10-07
3. Prognostic value of PSA bounce after definitive radiotherapy revisited;International Journal of Clinical Oncology;2021-10-22
4. Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2021-05-04
5. Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs;Brachytherapy;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3